Gilead Sciences Inc
Stock Chart, Company Information, and Scan Results
$113.18(as of Aug 1, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Gilead Sciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$113.18
Ticker SymbolGILD
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees17,600
CountyUSA
Market Cap$140,788.0M
EBIDTA13,724.0M
10-Day Moving Average112.89
P/E Ratio23.89
20-Day Moving Average111.86
Forward P/E Ratio14.25
50-Day Moving Average110.18
Earnings per Share4.76
200-Day Moving Average100.72
Profit Margin19.72%
RSI54.12
Shares Outstanding1,243.9M
ATR2.72
52-Week High118.28
Volume5,016,300
52-Week Low70.17
Book Value19,078.0M
P/B Ratio7.47
Upper Keltner117.97
P/S Ratio4.96
Lower Keltner105.75
Debt-to-Equity Ratio117.97
Next Earnings Date08/05/2025
Cash Surplus-4,417.0M
Next Ex-Dividend DateUnknown
Add good karma to your portfolio with GILD. This research-based biopharmaceutical company is making the world a better place by developing and commercializing medicines for life-threatening diseases like HIV/AIDS, liver diseases, and cancer. Gilead’s HIV treatments, including Truvada and Atripla, have helped transform the chronic disease into a manageable condition. Their treatments are responsible for saving millions of lives.
Gilead Sciences Inc In Our Stock Scanner
As of Aug 04, 2025
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.